SCHEMBL4124362

SCHEMBL4124362

N#Cc1nc(/C=C2\SC(=S)N(Cc3ccc4c(c3)OCO4)C2=O)oc1N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.48
▸ ALDH1A1 P00352 6/20 0.42
▸ LMNA P02545 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KMT2A Q03164 6/20 0.39
▸ MAPT P10636 6/20 0.39
▸ MEN1 O00255 5/20 0.39
▸ PKM P14618 4/20 0.39
▸ CMA1 P23946 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HPGD P15428 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ CRHBP P24387 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CRHR2 Q13324 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4124359 1.00 MAPK1 (0.48) MAPK1ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL4124365 1.00 MAPK1 (0.48) MAPK1ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL14220257 0.88 MAPK1 (0.50) MAPK1ALDH1A1LMNAKMT2AMAPT
SCHEMBL4140829 0.77 MAPK1 (0.54) MAPK1ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL4140832 0.77 MAPK1 (0.54) MAPK1ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL4133303 0.75 MAPK1 (0.60) MAPK1KMT2AMAPTMEN1CMA1
SCHEMBL4133305 0.75 MAPK1 (0.60) MAPK1KMT2AMAPTMEN1CMA1
SCHEMBL4138637 0.73 MAPK1 (0.72) MAPK1KMT2AMAPTMEN1PKM
SCHEMBL4138638 0.73 MAPK1 (0.72) MAPK1KMT2AMAPTMEN1PKM
SCHEMBL4144074 0.73 MAPK1 (0.62) MAPK1KMT2AMAPTMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885ALDH1A1 1858/4885LMNA 2841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback